215
Views
13
CrossRef citations to date
0
Altmetric
Articles

Reversal of P-glycoprotein-mediated multidrug resistance by the novel tetrandrine derivative W6

, , , , &
Pages 638-648 | Received 25 Feb 2015, Accepted 29 Apr 2015, Published online: 03 Aug 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Mohammad Feyzizadeh, Ashkan Barfar, Zeinab Nouri, Muhammad Sarfraz, Parvin Zakeri-Milani & Hadi Valizadeh. (2022) Overcoming multidrug resistance through targeting ABC transporters: lessons for drug discovery. Expert Opinion on Drug Discovery 17:9, pages 1013-1027.
Read now
Qian-Hao Yang, Cheng-Shi Jiang, Tao Jin, Jin-Fang Xu, Ting-Li Qu, Yue-Wei Guo & Zheng-Bao Zhao. (2018) Synthesis of novel tetrandrine derivatives and their inhibition against NSCLC A549 cells. Journal of Asian Natural Products Research 20:11, pages 1064-1074.
Read now

Articles from other publishers (11)

Xiu-zheng Gao, Xu-tao Lv, Rui-rui Zhang, Yang Luo, Mu-xuan Wang, Jia-shu Chen, Yu-kai Zhang, Bin Sun, Jin-yue Sun, Yu-fa Liu & Chao Liu. (2021) Design, synthesis and in vitro anticancer research of novel tetrandrine and fangchinoline derivatives. Bioorganic Chemistry 109, pages 104694.
Crossref
Fei Luan, Xirui He & Nan Zeng. (2020) Tetrandrine: a review of its anticancer potentials, clinical settings, pharmacokinetics and drug delivery systems. Journal of Pharmacy and Pharmacology 72:11, pages 1491-1512.
Crossref
Yachun Li, Dongjie Li, Ping Wang, Wei Zhu & Wanzhong Yin. (2020) Tetrandrine partially reverses multidrug resistance of human laryngeal cancer cells. Journal of International Medical Research 48:8, pages 030006052094470.
Crossref
Daniel Dantzic, Pawan Noel, Fabrice Merien, Dong-Xu Liu, Jun Lu, Haiyong Han, Mark McKeage & Yan Li. (2018) The Effects of Synthetically Modified Natural Compounds on ABC Transporters. Pharmaceutics 10:3, pages 127.
Crossref
Meng WANG, Ze-Fa LIU, Hua TANG & Bao-An CHEN. (2018) Application of alkaloids in reversing multidrug resistance in human cancers. Chinese Journal of Natural Medicines 16:8, pages 561-571.
Crossref
Viviana Calvillo-Páez, Rogerio R. Sotelo-Mundo, Mario Leyva-Peralta, Juan Carlos Gálvez-Ruiz, David Corona-Martínez, Ramón Moreno-Corral, Raymundo Escobar-Picos, Herbert Höpfl, Octavio Juárez-Sánchez & Karen Ochoa Lara. (2018) Synthesis, spectroscopic, physicochemical and structural characterization of tetrandrine-based macrocycles functionalized with acridine and anthracene groups: DNA binding and anti-proliferative activity. Chemico-Biological Interactions 286, pages 34-44.
Crossref
Piaoting Guo, Songpo Wang, Wei Liang, Wenjing Wang, Huijun Wang, Miaomiao Zhao & Xiaowei Liu. (2017) Salvianolic acid B reverses multidrug resistance in HCT-8/VCR human colorectal cancer cells by increasing ROS levels. Molecular Medicine Reports 15:2, pages 724-730.
Crossref
Fidelia Ijeoma Uche, Mohammed N. Abed, Marwan I. Abdullah, Falko P. Drijfhout, James McCullagh, Timothy W. D. Claridge, Alan Richardson & Wen-Wu Li. (2017) Isochondodendrine and 2′-norcocsuline: additional alkaloids from Triclisia subcordata induce cytotoxicity and apoptosis in ovarian cancer cell lines. RSC Advances 7:70, pages 44154-44161.
Crossref
Yuan Zhao, Meng-lei Huan, Miao Liu, Ying Cheng, Yang Sun, Han Cui, Dao-zhou Liu, Qi-bing Mei & Si-yuan Zhou. (2016) Doxorubicin and resveratrol co-delivery nanoparticle to overcome doxorubicin resistance. Scientific Reports 6:1.
Crossref
Sahar A. Khaleel, Ahmed M. Al-Abd, Azza A. Ali & Ashraf B. Abdel-Naim. (2016) Didox and resveratrol sensitize colorectal cancer cells to doxorubicin via activating apoptosis and ameliorating P-glycoprotein activity. Scientific Reports 6:1.
Crossref
Fahad Al-Abbasi, Eman Alghamdi, Mohammed Baghdadi, Abdulmohsin Alamoudi, Ali El-Halawany, Hany El-Bassossy, Ali Aseeri & Ahmed Al-Abd. (2016) Gingerol Synergizes the Cytotoxic Effects of Doxorubicin against Liver Cancer Cells and Protects from Its Vascular Toxicity. Molecules 21:7, pages 886.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.